Laurus Labs hits record high; rallies 17% in 7 days post Q1 results

The management holds a positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio -- and believes the outlook remains robust driven by improving demand and supported by capex

Shares of Laurus Labs hit a record high of Rs 705.95, up 4 per cent on the BSE in the intra-day trade on Monday, having rallied 17 per cent in the past seven trading days, after the company announced the financial results for the first quarter of financial year 2021-22 (Q1FY22).

The stock of pharmaceutical company surpassed its previous high of Rs 698 touched on June 29, 2021 amid a positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio -- by the management. It believes the outlook remains robust driven by improving demand and supported by